Table 1 Baseline characteristics of patients with fulminant myocarditis with extracorporeal membranous oxygenation (ECMO) support
Survivors ( n = 13) | Non-survivors ( n = 9) | P value | |
|---|---|---|---|
Age, years | 36.5 ± 14.7 | 60.2 ± 14.9 | 0.001 |
Male sex | 6 (46%) | 4 (44%) | 0.64 |
Systolic BP, mm Hg | 84.5 ± 21.7 | 81.4 ± 27.3 | 0.78 |
Heart rate, bpm | 110.0 ± 33.3 | 92.0 ± 26.1 | 0.22 |
Presence of pulseless VT or Vf | 9 (69%) | 6 (67%) | 0.90 |
LVDd, mm | 46.0 ± 7.7 | 44.0 ± 5.4 | 0.62 |
LVDs, mm | 40.7 ± 7.3 | 36.4 ± 4.2 | 0.25 |
LVEF, % | 22.9 ± 8.5 | 23.6 ± 12.6 | 0.88 |
Laboratory data on admission | |||
WBC (/μL) | 10,213.9 ± 5,431.6 | 11,937.8 ± 9,399.0 | 0.59 |
GOT (IU/L) | 768.6 ± 864.1 | 1,599.8 ± 2,759.7 | 0.40 |
GPT (IU/L) | 540.6 ± 726.9 | 1,044.2 ± 1,882.0 | 0.46 |
LDH (IU/L) | 2,187.9 ± 2,198.0 | 2,815.1 ± 4,245.1 | 0.65 |
Total-Bil (mg/dL) | 0.72 ± 0.29 | 0.85 ± 0.49 | 0.46 |
Direct-Bil (mg/dL) | 0.28 ± 0.11 | 0.37 ± 0.31 | 0.36 |
BUN (mg/dL) | 26.7 ± 12.4 | 38.9 ± 29.0 | 0.26 |
Creatinine (mg/dL) | 1.47 ± 0.76 | 1.48 ± 0.98 | 0.99 |
Max. CK (IU/L) | 3,090.2 ± 4,416.1 | 3,148.0 ± 4,456.2 | 0.98 |
Max. CK-MB (IU/L) | 154.9 ± 279.8 | 113.2 ± 70.1 | 0.67 |